Presence of α-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma

Journal of Hepatology

Volumn 31, Issue 2, 1999, Pages 332-339

  Matsumura, Masayuki ^a   Shiratori, Yasushi ^b   Niwa, Yasuro ^b   Tanaka, Torao ^b   Ogura, Keiji ^b   Okudaira, Takehito ^b   Imamura, Masatoshi ^b   Okano, Ken Ichi ^a   Shiina, Shuichiro ^b   Omata, Masao ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

AFP mRNA; Hepatocellular carcinoma; Outcome

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CORRELATION FUNCTION; DISEASE MARKER; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

EID: 0032776366     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80232-3     Document Type: Article

References (35)

1. Colombo M, de Franchis R, del Ninno E, Sangiovanni A, de Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med. 325:1991;675-680.
2. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology. 12:1990;680-687.
3. Matsumura M, Niwa Y, Kato N, Komatsu Y, Shiina S, Kawabe T, et al. Detection of α-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology. 20:1994;1418-1425.
4. Subramanyam BR, Balthazar EJ, Hilton S, Lefleur R, Horii S, Raghavendra B. Hepatocellular carcinoma with venous invasion. Sonographic angiographic correlation. Radiology. 150:1984;793-796.
5. Okuda K, Musha H, Yoshida T, Kanda Y, Yamazaki T, Jinnouchi S, et al. Demonstration of growing casts of hepatocellular carcinoma in the portal vein by celiac angiography: the thread and streaks sign. Radiology. 117:1975;303-309.
6. Mathieu D, Grenier P, Larde D, Vasile N. Portal vein involvement in hepatocellular carcinoma: dynamic CT features. Radiology. 152:1984;127-132.
7. Scharschmidt B. Human liver transplantation: an analysis of 819 patients from eight centers. Thomas H, Jones E, . Recent Advances in Hepatology. 1986;175 Churchill Livingstone, New York.
8. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer. 7:1954;462-503.
9. Hermanek P, Sobin LH. TNM Classification of Malignant Tumors, 4th ed. 1987;53-55 Springer Verlag, Tokyo.
10. Shiina S, Niwa Y, Shiratori Y, Akira T, Omata M. Percutaneous ethanol injection therapy for hepatocellular carcinoma (review). Int J Oncol. 2:1993;669-675.
11. O'Halpin D, Legge D, MacErlean DP. Therapeutic arterial embolization: report of five years' experience. Clin Radiol. 35:1984;85-93.
12. Bartolozzi C, Lencioni R, Caramella D, Vignali C, Cioni R, Mazzeo S, et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology. 197:1995;812-818.
13. Tanaka K, Okazaki H, Nakamura S, Endo O, Inoue S, Takamura Y, et al. Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection. Radiology. 179:1991;713-717.
14. Bartolozzi C, Lencioni R, Caramella D, Falaschi F, Cioni R, DiCoscio G. Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. Radiology. 191:1994;123-128.
15. Kobayashi K, Sugimoto T, Makino H, Kumagai M, Unoura M, Tanaka N. Screening methods for early detection of hepatocellular carcinoma. Hepatology. 5:1985;1100-1105.
16. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology. 6:1986;729-738.
17. Tanaka S, Kitamura T, Nakanishi K, Okuda S, Yamazaki H, Hiyama T. Effectiveness of periodic checkup by ultrasonography for the early diagnosis of hepatocellular carcinoma. Cancer. 66:1990;2210-2214.
18. Matsumura M, Niwa Y, Hikiba Y, Okano K, Kato N, Shiina S, et al. Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha-fetoprotein mRNA) in blood. Biochem Biophys Res Commun. 207:1995;813-818.
19. Hayashi N, Yanagisawa A, Kato Y, Nakamori S, Imaoka S, Watanabe H, et al. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet. 345:1995;1257-1259.
20. Yamanaka N, Okamoto E, Fujihara S, Kato T, Fujimoto J, Oriyama T, Mitusunobu M, et al. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection? Cancer. 70:1992;2263-2267.
21. Ferris JV, Baron RL, Marsh JW, Oliver JH, Carr BI, Dodd III GD. Recurrence of hepatocellular carcinoma after liver transplantation: spectrum of CT findings and recurrence patterns. Radiology. 198:1996;233-238.
22. Hillaire S, Barbu V, Boucher E, Moukhter M, Poupon R. Albumin mRNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterology. 106:1994;239-242.
23. Kar S, Carr BI. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatology. 21:1995;403-407.
24. Chou H, Sheu J, Huang G, Wang J, Chen D. Albumin messenger RNA is not specific for circulating hepatoma cells. Gastroenterology. 107:1994;630-631.
25. Niwa Y, Matsumura M, Shiratori Y, Imamura M, Kato N, Shiina S, et al. Quantitation of alpha fetoprotein and albumin mesenger RNAs in human hepatocellular carcinoma. Hepatology. 23:1996;1384-1392.
26. Funaki NO, Tanaka J, Seto S, Kasamatsu T, Kaido T, Imamura M. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology. 25:1997;564-568.
27. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer. 64:1989;1700-1707.
28. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med. 334:1996;693-699.
29. Liotta L, Steeg P, Stetler-Stevenson W. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 64:1991;327-336.
30. Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR. 160:1993;1023-1028.
31. Ringe B, Wittekind C, Bechstein W, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobilliary malignancy: a retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg. 209:1989;88-98.
32. O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease: result in 93 consecutive patients. Ann Surg. 207:1988;373-379.
33. Iwatsuki S, Gordon RD, Shaw BWJ, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg. 202:1985;401-407.
34. McPeake J, Williams R. Liver transplantation for hepatocellular carcinoma. Gut. 36:1995;644-646.
35. Olthoff KM, Rosove MH, Shackleton CR, Omagawa DK. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg. 221:1995;734-741.